BEPROGEL TOPICAL SOLUTION

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktīvā sastāvdaļa:

BETAMETHASONE DIPROPIONATE

Pieejams no:

HOE PHARMACEUTICALS SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

BETAMETHASONE DIPROPIONATE

Vienības iepakojumā:

30ml mL

Ražojis:

HOE PHARMACEUTICALS SDN. BHD.

Lietošanas instrukcija

Consumer Medication Information Leaflet (RiMUP)
BEPROGEL TOPICAL SOLUTION
Betamethasone Dipropionate (0.064% w/w)
1
What is in this leaflet
1.
What
BEPROGEL
TOPICAL
SOLUTION is used for
2.
How
BEPROGEL
TOPICAL
SOLUTION works
3.
Before
you
use
BEPROGEL
TOPICAL SOLUTION
4.
How
to
use
BEPROGEL
TOPICAL SOLUTION
5.
While
you
are
using
BEPROGEL
TOPICAL
SOLUTION
6.
Side effects
7.
Storage
and
disposal
of
BEPROGEL
TOPICAL
SOLUTION
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
This leaflet answers some common
questions
about
BEPROGEL
TOPICAL SOLUTION. It does not
contain all the available information.
It does not take the place of talking to
your pharmacist or doctor.
Keep this leaflet with the medicine.
You may need to read it again.
What BEPROGEL TOPICAL
SOLUTION is used for
BEPROGEL TOPICAL SOLUTION
is used to suppress of skin disease in
which inflammation is a prominent
feature. These skin problems include
eczema, atopic dermatitis, dermatitis
herpetiformis,
contact
dermatitis,
dermatitis
venenata,
seborrhoeic
dermatitis, neurodermatitis, psoriasis
and intertrigo.
How BEPROGEL TOPICAL
SOLUTION works
BEPROGEL TOPICAL SOLUTION
contains
a
medicine
called
betamethasone
dipropionate.
It
belongs
to
a
group
of
medicines
called
steroids.
It
has
anti-
inflammatory,
anti-itchiness
and
blood vessel narrowing actions.
Ask your pharmacist or doctor if you
have
any
questions
about
this
medicine.
Before
you
use
BEPROGEL
TOPICAL SOLUTION
-When you must not use it
Do not use this medicine if:
•
You
are
hypersensitive
to
other
corticosteroids
or
any
of
this
medicine related ingredients.
•
You
have
viral
skin
infections,
tuberculosis
(bacteria
infection),
and acne.
-Before you start to use it
Tell your pharmacist or doctor if you
are using any other skin products.
Pregnancy and breast feeding
Ask your doctor or pharmacist for
advice before taking this medicine if
you are pregnant or breast-feeding.
-Taking other medicines
Tell your pharmacist or doctor if you
are taking any other product

Produkta apraksts

BEPROGEL TOPICAL SOLUTION
Est. 1979
NAME AND STRENGTH OF ACTIVE SUBSTANCE: Betamethasone dipropionate
0.064% w/v
(equiv. to Betamethasone 0.05% w/v).
PRODUCT DESCRIPTION: A colourless and slightly viscous solution.
Other ingredients: Hydroxypropyl Methylcellulose, Methylparaben,
Isopropyl alcohol,
Hydrochloric acid and Purified water.
PHARMACODYNAMIC : Betamethasone dipropionate has anti-inflammatory,
anti-pruritic, and
vasoconstrictive actions.
PHARMACOKINETICS : When administered topically, particularly under
occlusive dressings or
when the skin is broken, sufficient corticosteroid may be absorbed to
give systemic effects.
Corticosteroids are extensively bound to plasma proteins. Only unbound
corticosteroids have
pharmacological effects or are metabolized. They are metabolized
mainly in the liver, also in the
kidneys, and are excreted in the urine.
INDICATIONS : Suppression of skin diseases in which inflammation is a
prominent feature, eg.
eczema, atopic dermatitis, dermatitis herpetiformis, contact
dermatitis, dermatitis venenata,
seborrhoeic dermatitis, neurodermatitis, psoriasis and intertrigo.
CONTRAINDICATIONS: Hypersensitivity to betamethasone dipropionate,
other corticosteroids,
or any component in the base. Topical corticosteroids are
contraindicated in most viral infections
of the skin, such as vaccinia, varicella, and Herpes simplex, also
tuberculosis and acne rosacea.
ADVERSE EFFECTS : Report local adverse reactions are burning, itching,
irritation, dryness
folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation,
maceration of the skin,
secondary infection, skin atrophy, striae and miliaria. Large doses of
corticosteroids may
produce symptoms typical of hyperactivity of the adrenal cortex, with
moon face, sometimes with
hirsutism, buffalo hump, flushing, sometimes leading to a fully
developed Cushing's syndrome.
Systemic adverse reactions, such as vision blurred, have also been
reported with the use of
topical corticosteroids.
DRUG INTERACTION : Unknown.
ROUTE OF ADMINISTRATION : Topical.